Many cancer patients are interested in complementary and alternative medicine. I help patients understand how some of these therapies can help while others can be counter-productive. I also counsel patients on what else they can do to help themselves before, during, and after cancer treatment, taking advantage of what integrative medicine has to offer. Integrative medicine can reduce symptoms, improve quality of life, facilitate disease prevention, and promote wellness.
I am a principal investigator of several research projects on acupuncture and botanical/herbal agents, which are funded by the National Institutes of Health. I have authored review articles and medical textbook chapters on Integrative Medicine. These include “Integrative Oncology Clinical Practice Guidelines” adopted by the Society of Integrative Oncology and American College of Chest Physicians, and “Integrative Medicine Research: Context and Priorities” commissioned by the Institute of Medicine of the National Academy of Sciences. I have a particular interest in physician education. I am also active in the professional community and serve as the current president of the Society for Integrative Oncology.
- Clinical Expertise: Integrative Medicine
- Languages Spoken: English
- Education: MD, Beijing Medical University (China); PhD, University of Miami
- Residencies: The University of Texas Medical School at Houston
- Board Certifications: Internal Medicine
Deng GE, Rausch SM, Jones LW, et al. Complementary therapies and integrative medicine in lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. May 2013; 143(5 Suppl): e420S-36S
Deng G, Kurtz RC, Vickers A, et al. A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients. J Ethnopharmacol. Apr 17 2011.
Deng GE, Frenkel M, Cohen L, et al. Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals. Journal of the Society for Integrative Oncology. Summer 2009; 7(3): 85-120
Deng G, Lin H, Seidman A, et al. A phase I/II trial of a polysaccharide extract from Grifola frondosa (Maitake mushroom) in breast cancer patients: immunological effects. J Cancer Res Clin Oncol. Sep 2009; 135(9): 1215-1221
Cassileth BR, Rizvi N, Deng G, et al. Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patients. Cancer Chemother Pharmacol. Dec 2009; 65(1): 67-71
Deng G, Hou BL, Holodny AI, Cassileth BR. Functional magnetic resonance imaging (fMRI) changes and saliva production associated with acupuncture at LI-2 acupuncture point: a randomized controlled study. BMC Complement Altern Med. 2008;8:37
Deng G, Vickers A, Yeung S, Cassileth B.. Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients.. Journal of Clinical Oncology Dec 31, 2007; 25(35) :5546-7
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.